90508314

Information

  • Trademark
  • 90508314
  • Serial Number
    90508314
  • Filing Date
    February 03, 2021
    5 years ago
  • Transaction Date
    July 12, 2024
    a year ago
  • Status Date
    June 24, 2024
    a year ago
  • Published for Opposition Date
    September 28, 2021
    4 years ago
  • Location Date
    November 23, 2021
    4 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    JACKSON, SHA-KARA ELOU
  • Attorney Docket Number
    1236132
    Attorney Name
    R. Gwen Peterson
    Law Office Assigned Location Code
    L10
  • Owners
Mark Drawing Code
2
Case File Statements
  • DM0000: The mark consists of a geometric design composed of three arrows pointing inward on a background that forms its own multi-sided geometric design with three distinct sections, each corresponding to one of the arrows, and three arrowheads pointing inwards. The black in the drawing is intended to show background and shading.
  • GS0051: Biologics for medical use, namely, biological preparations for the treatment or prophylaxis of cancer; biologics for medical use, namely, biological preparations for the treatment or prophylaxis of infectious diseases; pharmaceutical preparations, biologics and antibodies for the treatment of oncological, infectious disease, and immune system related diseases, disorders and conditions; diagnostic agents, preparations and substances for medical purposes; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic preparations, biologics and antibodies for medical purposes, namely, for detecting the presence of malignant, inflammatory, infectious and autoimmune diseases, disorders and conditions in humans
  • GS0011: Diagnostic preparations for clinical use and scientific research; biological tissue cultures for clinical use and scientific research; antibodies for clinical use and scientific research; combinations of biological tissue cultures for clinical use and scientific research; and combinations of antibodies for clinical use and scientific research
  • GS0421: Biological and pharmaceutical research and development; research, design and development of diagnostics for predicting the response of patients to therapeutics; research, design and development of biologics; research, design and development of combinations of such diagnostics and biologics; molecular biology research for diagnostic preparations, biologics, combinations of diagnostic preparations and biologics, and diagnostic kits for scientific research use; scientific research in the field of cancer and infectious disease treatment and diagnosis; providing laboratory research services in the field of cancer biology and infectious disease biology; testing, inspection, research and development of pharmaceutical preparations for cancer and infectious diseases; providing laboratory research services in the field of cancer biology and infectious diseases; research and development services in the field of antibodies; providing medical and scientific research information in the fields of cancer research, infectious disease research and disease classification; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Case File Event Statements
  • 2/6/2021 - 5 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 5/6/2021 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/7/2021 - 5 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 8/24/2021 - 4 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/25/2021 - 4 years ago
    5 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/27/2021 - 4 years ago
    6 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 8/27/2021 - 4 years ago
    7 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 9/28/2021 - 4 years ago
    11 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/27/2021 - 4 years ago
    8 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 9/8/2021 - 4 years ago
    9 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 9/28/2021 - 4 years ago
    10 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 11/23/2021 - 4 years ago
    12 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 5/11/2022 - 4 years ago
    13 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 5/11/2022 - 4 years ago
    14 - SOU EXTENSION 1 FILED Type: EXT1
  • 5/11/2022 - 4 years ago
    15 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 5/13/2022 - 4 years ago
    16 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 10/3/2022 - 3 years ago
    17 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 10/3/2022 - 3 years ago
    18 - SOU EXTENSION 2 FILED Type: EXT2
  • 10/3/2022 - 3 years ago
    19 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 10/5/2022 - 3 years ago
    20 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 5/3/2023 - 3 years ago
    21 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 5/3/2023 - 3 years ago
    22 - SOU EXTENSION 3 FILED Type: EXT3
  • 5/3/2023 - 3 years ago
    23 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 5/5/2023 - 3 years ago
    24 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 10/5/2023 - 2 years ago
    25 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 10/5/2023 - 2 years ago
    26 - SOU EXTENSION 4 FILED Type: EXT4
  • 10/5/2023 - 2 years ago
    27 - SOU EXTENSION 4 GRANTED Type: EX4G
  • 10/7/2023 - 2 years ago
    28 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 6/24/2024 - a year ago
    29 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 7/12/2024 - a year ago
    30 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6